PDCD1 and cancer: The surfaces of this nanovesicle are equipped with PD-1 and TGF-β receptors, which can cut off the PD-L1 pathway on cancer cells and clear TGF-β secretion, ultimately killing cancer cells and preventing cytotoxic-T-cell exhaustion [128].